|Articles|June 13, 2022
Syner-G Biopharma Group Appoints Ron Kraus as CEO
Kraus brings more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.
Advertisement
Syner-G BioPharma Group announced that Ron Kraus has joined the company as Chief Executive Officer (CEO). Kraus has more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.
Prior to joining Syner-G, Kraus was Chief Operating Officer at Cytel. He succeeds Syner-G’s founder, Prabu Nambiar, PhD, MBA, RAC, as CEO.
Read more about Kraus' appointment
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
2
Beyond the Molecule: The New Competitive Battlefield in Oncology
3
FDA Approves Beqalzi for Relapsed or Refractory Mantle Cell Lymphoma, Inqovi in Combination with Venetoclax
4
Being an Expert Is About More Than Just Knowing the Answers
5